STUB1 and coronary artery disorder: The 5‐year cumulative incidence of death after CHD for those who were CHIP+/AgeAccelHG+ was 58.5%, while for all other groups it was substantially lower (CHIP+/AgeAccelHG− 18.8%, CHIP−/AgeAccelHG+ 20.0%, CHIP−/AgeAccelHG− 19.8%, Figure 2F).